Immunis is a biotechnology company developing treatments for age-related and disease-related immune deficits. It specializes in creating methods to grow human stem cells for clinical use and direct them to become populations of defined cells that secrete factors which benefit immune system development, modulation, and health. The company focuses on developing immunomodulatory secretome products that target muscle atrophy.